Archive: Sun May 2017

Remove the For-Profit Variable from Clinical Drug Trials

Fran Quigley At first glance, it seems that clinical trials are the much-criticized pharmaceutical industry’s best contribution to the medicines process. The industry leans on governments to fund early-stage research, then claims the patent rights to…